stockrowWarby Parker Inc.
WRBY Healthcare Medical Instruments & Supplies
Warby Parker Inc.’s revenue for fiscal 2025 (year ended December 2025) was $871.9 million, up 13.0% from fiscal 2024.
- Revenue
- +10.4%
- EPS
- −20.0%
- Free cash flow
- −30.3%
Quarter to September 2026, against a year earlier
Follow WRBY
Alert me
Warby Parker Inc. (WRBY) Free cash flow
Warby Parker Inc.'s free cash flow for fiscal 2025 was $43.7M, up 26.0% from $34.7M in fiscal 2024. Over the twelve months to 30 September 2026 it was $21.3M. Over the past ten years it has ranged from −$80.5M (fiscal 2021) to $43.7M (fiscal 2025) — the current reading is the highest in ten years. Free cash flow has risen for 4 consecutive fiscal years. Warby Parker Inc. ranks 22nd of 51 Medical Instruments & Supplies companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $43.7M | 26.00% |
| FY2024 | $34.7M | 374.21% |
| FY2023 | $7.3M | — |
| FY2022 | −$49.8M | — |
| FY2021 | −$80.5M | — |
| FY2020 | $12.7M | — |
| FY2019 | −$11.2M | — |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Sep 2026 | −$2.0M | — |
| Jun 2026 | $6.8M | (19.32%) |
| Mar 2026 | $8.4M | 2.94% |
| Dec 2025 | $8.1M | — |
| 22 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| ICUI ICU Medical, Inc. compare | $272.2M |
| XRAY DENTSPLY SIRONA Inc. compare | $272.0M |
| LMAT LeMaitre Vascular, Inc. compare | $67.0M |
| ATRC AtriCure, Inc. compare | $52.9M |
| WRBY Warby Parker Inc. | $21.3M |
| AZTA Azenta, Inc. compare | $9.9M |
| STVN Stevanato Group S.p.A. compare | −$8.8M |
| KMTS Kestra Medical Technologies, Ltd. compare | −$123.1M |
| PLSE Pulse Biosciences, Inc compare | −$216.1M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on WRBY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement